Annual Gross Profit
$13.17 M
-$4.62 M-25.99%
31 December 2023
Summary:
Aclaris Therapeutics annual gross profit is currently $13.17 million, with the most recent change of -$4.62 million (-25.99%) on 31 December 2023. During the last 3 years, it has risen by +$11.82 million (+876.13%). ACRS annual gross profit is now -25.99% below its all-time high of $17.79 million, reached on 31 December 2022.ACRS Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$1.94 M
+$1.08 M+126.14%
30 September 2024
Summary:
Aclaris Therapeutics quarterly gross profit is currently $1.94 million, with the most recent change of +$1.08 million (+126.14%) on 30 September 2024. Over the past year, it has increased by +$848.00 thousand (+77.80%). ACRS quarterly gross profit is now -82.61% below its all-time high of $11.14 million, reached on 31 December 2023.ACRS Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$14.49 M
+$848.00 K+6.21%
30 September 2024
Summary:
Aclaris Therapeutics TTM gross profit is currently $14.49 million, with the most recent change of +$848.00 thousand (+6.21%) on 30 September 2024. Over the past year, it has increased by +$6.23 million (+75.38%). ACRS TTM gross profit is now -20.15% below its all-time high of $18.15 million, reached on 31 March 2023.ACRS TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS Gross Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -26.0% | +77.8% | +75.4% |
3 y3 years | +876.1% | +246.1% | +628.4% |
5 y5 years | +622.7% | +1134.4% | +2272.3% |
ACRS Gross Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -26.0% | +876.1% | -82.6% | +599.6% | -20.1% | +768.0% |
5 y | 5 years | -26.0% | +7555.8% | -82.6% | +2750.0% | -20.1% | +8278.6% |
alltime | all time | -26.0% | -82.6% | +1894.4% | -20.1% |
Aclaris Therapeutics Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $1.94 M(+126.1%) | $14.49 M(+6.2%) |
June 2024 | - | $857.00 K(+53.6%) | $13.65 M(+4.4%) |
Mar 2024 | - | $558.00 K(-95.0%) | $13.07 M(-0.8%) |
Dec 2023 | $13.17 M(-26.0%) | $11.14 M(+922.2%) | $13.17 M(+59.3%) |
Sept 2023 | - | $1.09 M(+293.5%) | $8.27 M(-54.0%) |
June 2023 | - | $277.00 K(-58.0%) | $17.97 M(-1.0%) |
Mar 2023 | - | $659.00 K(-89.4%) | $18.15 M(+2.0%) |
Dec 2022 | $17.79 M(+768.8%) | $6.24 M(-42.2%) | $17.79 M(+49.4%) |
Sept 2022 | - | $10.79 M(+2246.7%) | $11.90 M(+612.9%) |
June 2022 | - | $460.00 K(+54.4%) | $1.67 M(-5.7%) |
Mar 2022 | - | $298.00 K(-15.3%) | $1.77 M(-13.5%) |
Dec 2021 | $2.05 M(+51.8%) | $352.00 K(-37.1%) | $2.05 M(+2.9%) |
Sept 2021 | - | $560.00 K(-0.2%) | $1.99 M(+17.8%) |
June 2021 | - | $561.00 K(-2.4%) | $1.69 M(-5.4%) |
Mar 2021 | - | $575.00 K(+95.6%) | $1.79 M(+32.4%) |
Dec 2020 | $1.35 M | $294.00 K(+13.1%) | $1.35 M(+20.1%) |
Sept 2020 | - | $260.00 K(-60.4%) | $1.12 M(+10.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2020 | - | $657.00 K(+376.1%) | $1.02 M(+300.0%) |
Mar 2020 | - | $138.00 K(+102.9%) | $255.00 K(+47.4%) |
Dec 2019 | $172.00 K(-90.6%) | $68.00 K(-56.7%) | $173.00 K(-71.7%) |
Sept 2019 | - | $157.00 K(-245.4%) | $611.00 K(+21.0%) |
June 2019 | - | -$108.00 K(-292.9%) | $505.00 K(-83.8%) |
Mar 2019 | - | $56.00 K(-88.9%) | $3.11 M(-3.0%) |
Dec 2018 | $1.82 M(+282.8%) | $506.00 K(+892.2%) | $3.20 M(+8.9%) |
Sept 2018 | - | $51.00 K(-98.0%) | $2.94 M(-5.8%) |
June 2018 | - | $2.50 M(+1552.3%) | $3.12 M(+397.9%) |
Mar 2018 | - | $151.00 K(-38.4%) | $627.00 K(+31.7%) |
Dec 2017 | $476.00 K(>+9900.0%) | $245.00 K(+6.1%) | $476.00 K(+106.1%) |
Sept 2017 | - | $231.00 K(>+9900.0%) | $231.00 K(>+9900.0%) |
June 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2016 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sept 2016 | - | $0.00 | $0.00 |
Dec 2015 | $0.00 | - | - |
FAQ
- What is Aclaris Therapeutics annual gross profit?
- What is the all time high annual gross profit for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual gross profit year-on-year change?
- What is Aclaris Therapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly gross profit year-on-year change?
- What is Aclaris Therapeutics TTM gross profit?
- What is the all time high TTM gross profit for Aclaris Therapeutics?
- What is Aclaris Therapeutics TTM gross profit year-on-year change?
What is Aclaris Therapeutics annual gross profit?
The current annual gross profit of ACRS is $13.17 M
What is the all time high annual gross profit for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual gross profit is $17.79 M
What is Aclaris Therapeutics annual gross profit year-on-year change?
Over the past year, ACRS annual gross profit has changed by -$4.62 M (-25.99%)
What is Aclaris Therapeutics quarterly gross profit?
The current quarterly gross profit of ACRS is $1.94 M
What is the all time high quarterly gross profit for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly gross profit is $11.14 M
What is Aclaris Therapeutics quarterly gross profit year-on-year change?
Over the past year, ACRS quarterly gross profit has changed by +$848.00 K (+77.80%)
What is Aclaris Therapeutics TTM gross profit?
The current TTM gross profit of ACRS is $14.49 M
What is the all time high TTM gross profit for Aclaris Therapeutics?
Aclaris Therapeutics all-time high TTM gross profit is $18.15 M
What is Aclaris Therapeutics TTM gross profit year-on-year change?
Over the past year, ACRS TTM gross profit has changed by +$6.23 M (+75.38%)